Cargando…

Design and In Vitro Evaluation of Compression-coated Pulsatile Release Tablets of Losartan Potassium

In majority of individuals blood pressure rises in the early morning hours, which lead to serious cardiovascular complications. Formulation of pulsatile system makes it possible to deliver drug at definite period of time when symptoms of the disease condition are most critical. The purpose of the pr...

Descripción completa

Detalles Bibliográficos
Autores principales: Bajpai, M., Singh, D. C. P., Bhattacharya, A., Singh, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546325/
https://www.ncbi.nlm.nih.gov/pubmed/23325989
http://dx.doi.org/10.4103/0250-474X.103839
_version_ 1782256035222781952
author Bajpai, M.
Singh, D. C. P.
Bhattacharya, A.
Singh, A.
author_facet Bajpai, M.
Singh, D. C. P.
Bhattacharya, A.
Singh, A.
author_sort Bajpai, M.
collection PubMed
description In majority of individuals blood pressure rises in the early morning hours, which lead to serious cardiovascular complications. Formulation of pulsatile system makes it possible to deliver drug at definite period of time when symptoms of the disease condition are most critical. The purpose of the present work was to develop pulsatile release tablet of losartan potassium for chronotherapy in hypertension. The prepared system consisted of a core tablet coated with versatile and safe hydrophilic cellulosic ethers such as, hydroxypropyl methylcellulose, hydroxypropyl cellulose and sodium carboxy methylcellulose to produce burst release after predetermined lag time. Various formulation factors were studied through series of test and in vitro dissolution study. It was found that core tablets containing superdisintegrant failed to produce burst drug release pattern while effervescent agent was able to do so. Results also reveal that coating composition and coating level affects lag time. Formulation containing effervescent agent in core and coated with 200 mg hydroxypropyl cellulose provide lag time of 4.5 h with 73% drug release in 6 h that followed a sigmoidal release pattern. These values were close to the desired objective of producing lag time of 5-6 h followed by fast drug release. This approach can thus provide a useful means for timed release of losartan and is helpful for patients with morning surge.
format Online
Article
Text
id pubmed-3546325
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-35463252013-01-16 Design and In Vitro Evaluation of Compression-coated Pulsatile Release Tablets of Losartan Potassium Bajpai, M. Singh, D. C. P. Bhattacharya, A. Singh, A. Indian J Pharm Sci Research Paper In majority of individuals blood pressure rises in the early morning hours, which lead to serious cardiovascular complications. Formulation of pulsatile system makes it possible to deliver drug at definite period of time when symptoms of the disease condition are most critical. The purpose of the present work was to develop pulsatile release tablet of losartan potassium for chronotherapy in hypertension. The prepared system consisted of a core tablet coated with versatile and safe hydrophilic cellulosic ethers such as, hydroxypropyl methylcellulose, hydroxypropyl cellulose and sodium carboxy methylcellulose to produce burst release after predetermined lag time. Various formulation factors were studied through series of test and in vitro dissolution study. It was found that core tablets containing superdisintegrant failed to produce burst drug release pattern while effervescent agent was able to do so. Results also reveal that coating composition and coating level affects lag time. Formulation containing effervescent agent in core and coated with 200 mg hydroxypropyl cellulose provide lag time of 4.5 h with 73% drug release in 6 h that followed a sigmoidal release pattern. These values were close to the desired objective of producing lag time of 5-6 h followed by fast drug release. This approach can thus provide a useful means for timed release of losartan and is helpful for patients with morning surge. Medknow Publications & Media Pvt Ltd 2012 /pmc/articles/PMC3546325/ /pubmed/23325989 http://dx.doi.org/10.4103/0250-474X.103839 Text en Copyright: © Indian Journal of Pharmaceutical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Paper
Bajpai, M.
Singh, D. C. P.
Bhattacharya, A.
Singh, A.
Design and In Vitro Evaluation of Compression-coated Pulsatile Release Tablets of Losartan Potassium
title Design and In Vitro Evaluation of Compression-coated Pulsatile Release Tablets of Losartan Potassium
title_full Design and In Vitro Evaluation of Compression-coated Pulsatile Release Tablets of Losartan Potassium
title_fullStr Design and In Vitro Evaluation of Compression-coated Pulsatile Release Tablets of Losartan Potassium
title_full_unstemmed Design and In Vitro Evaluation of Compression-coated Pulsatile Release Tablets of Losartan Potassium
title_short Design and In Vitro Evaluation of Compression-coated Pulsatile Release Tablets of Losartan Potassium
title_sort design and in vitro evaluation of compression-coated pulsatile release tablets of losartan potassium
topic Research Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3546325/
https://www.ncbi.nlm.nih.gov/pubmed/23325989
http://dx.doi.org/10.4103/0250-474X.103839
work_keys_str_mv AT bajpaim designandinvitroevaluationofcompressioncoatedpulsatilereleasetabletsoflosartanpotassium
AT singhdcp designandinvitroevaluationofcompressioncoatedpulsatilereleasetabletsoflosartanpotassium
AT bhattacharyaa designandinvitroevaluationofcompressioncoatedpulsatilereleasetabletsoflosartanpotassium
AT singha designandinvitroevaluationofcompressioncoatedpulsatilereleasetabletsoflosartanpotassium